agilon health (NYSE:AGL) Stock Price Down 7.8% - Here's Why

agilon health, inc. (NYSE:AGL - Get Free Report) was down 7.8% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.02. Approximately 1,872,278 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 4,848,195 shares. The stock had previously closed at $2.19.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Royal Bank of Canada reissued an "outperform" rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Barclays reduced their price objective on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a research note on Monday, November 11th. Bank of America lowered agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price for the company. in a research report on Wednesday, October 2nd. William Blair lowered agilon health from an "outperform" rating to a "market perform" rating in a research report on Friday, November 8th. Finally, Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research report on Tuesday, October 8th. Three equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, agilon health presently has a consensus rating of "Hold" and a consensus target price of $4.28.

agilon health Price Performance

The business has a 50-day moving average of $2.42 and a 200 day moving average of $4.35. The firm has a market capitalization of $824.04 million, a P/E ratio of -2.15 and a beta of 0.51. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the company earned ($0.06) earnings per share. On average, sell-side analysts predict that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Insider Activity at agilon health

In other news, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company's stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the company's stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 90,000 shares of company stock valued at $198,100. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of agilon health

Institutional investors and hedge funds have recently modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health in the third quarter valued at about $28,000. City State Bank purchased a new position in agilon health in the third quarter valued at approximately $52,000. CWM LLC grew its holdings in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Nisa Investment Advisors LLC bought a new position in shares of agilon health in the second quarter valued at approximately $60,000. Finally, Allspring Global Investments Holdings LLC grew its stake in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock valued at $70,000 after acquiring an additional 10,674 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.